STATE-OF-THE-ART PAPER
Role of Imaging in Cardiac Stem Cell Therapy
Saskia L.M.A. Beeres, MD*,
Frank M. Bengel, MD ,
Jozef Bartunek, MD ,
Douwe E. Atsma, MD*,
Jonathan M. Hill, MD ,
Marc Vanderheyden, MD ,
Martin Penicka, MD||,
Martin J. Schalij, MD*,
William Wijns, MD and
Jeroen J. Bax, MD*,*
* Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
Division of Nuclear Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Cardiovascular Center Aalst, Aalst, Belgium
Department of Cardiovascular Diseases, King's College, London, United Kingdom
|| CardioCenter, 3rd Medical School, Charles University and University Hospital, Prague, Czech Republic
Manuscript received August 28, 2006;
revised manuscript received October 11, 2006,
accepted October 23, 2006.
* Reprint requests and correspondence: Dr. Jeroen J. Bax, Department of Cardiology, C5-P, Leiden University Medical Center, P.O. Box 9600, 2300RC Leiden, the Netherlands. (Email: jbax{at}knoware.nl).
Stem cell therapy has emerged as a potential therapeutic option for cell death-related heart diseases. Preclinical and a number of early phase human studies suggested that cell therapy may augment perfusion and increase myocardial contractility. The rapid translation into clinical trials has left many issues unresolved, and emphasizes the need for specific techniques to visualize the mechanisms involved. Furthermore, the clinical efficacy of cell therapy remains to be proven. Imaging allows for in vivo tracking of cells and can provide a better understanding in the evaluation of the functional effects of cell-based therapies. In this review, a summary of the most promising imaging techniques for cell tracking is provided. Among these are direct labeling of cells with super-paramagnetic agents, radionuclides, and the use of reporter genes for imaging of transplanted cells. In addition, a comprehensive summary is provided of the currently available studies investigating a cell therapy-related effect on left ventricular function, myocardial perfusion, scar tissue, and myocardial viability.
|
Abbreviations and Acronyms
| | CT = computed tomography | | FDG = fluorodeoxyglucose | | HMPAO = exametazime | | LV = left ventricle/ventricular | | LVEDV = left ventricular end-diastolic volume | | LVEF = left ventricular ejection fraction | | MRI = magnetic resonance imaging | | PET = positron emission tomography | | SPECT = single-photon emission computed tomography |
|
This article has been cited by other articles:

|
 |

|
 |
 
V. Schachinger, A. Aicher, N. Dobert, R. Rover, J. Diener, S. Fichtlscherer, B. Assmus, F. H. Seeger, C. Menzel, W. Brenner, et al.
Pilot Trial on Determinants of Progenitor Cell Recruitment to the Infarcted Human Myocardium
Circulation,
September 30, 2008;
118(14):
1425 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Marwick and M. Schwaiger
The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 2: Clinical Applications
Circ Cardiovasc Imaging,
September 1, 2008;
1(2):
162 - 170.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L M A Beeres, D. E Atsma, J. van Ramshorst, M. J Schalij, and J. J Bax
Cell therapy for ischaemic heart disease
Heart,
September 1, 2008;
94(9):
1214 - 1226.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Carr, D. J. Stuckey, L. Tatton, D. J. Tyler, S. J. M. Hale, D. Sweeney, J. E. Schneider, E. Martin-Rendon, G. K. Radda, S. E. Harding, et al.
Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study
Am J Physiol Heart Circ Physiol,
August 1, 2008;
295(2):
H533 - H542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Marwick and M. Schwaiger
The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools
Circ Cardiovasc Imaging,
July 1, 2008;
1(1):
58 - 69.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Akins and P. Dubey
Noninvasive Imaging of Cell-Mediated Therapy for Treatment of Cancer
J. Nucl. Med.,
June 1, 2008;
49(Suppl_2):
180S - 195S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Doyle, B. J. Kemp, P. Chareonthaitawee, C. Reed, J. Schmeckpeper, P. Sorajja, S. Russell, P. Araoz, S. J. Riederer, and N. M. Caplice
Dynamic Tracking During Intracoronary Injection of 18F-FDG-Labeled Progenitor Cell Therapy for Acute Myocardial Infarction
J. Nucl. Med.,
October 1, 2007;
48(10):
1708 - 1714.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|